Ingram JR - Search Results

1

Hidradenitis Suppurativa Area and Severity Index (HASI): a pilot study to develop a novel instrument to measure the physical signs of hidradenitis suppurativa.

Goldfarb N, Ingram JR, Jemec GBE, Naik HB, Piguet V, Hyde MJ, Freese R, Lowes MA, Alavi A. Goldfarb N, et al. Among authors: ingram jr. Br J Dermatol. 2020 Jan;182(1):240-242. doi: 10.1111/bjd.18335. Epub 2019 Sep 17. Br J Dermatol. 2020. PMID: 31286486 Free PMC article. No abstract available.

2

Combination treatment with a tumour necrosis factor antagonist and an oral retinoid: efficacy in severe acral psoriasis?

Ingram JR, Anstey AV, Piguet V. Ingram JR, et al. Br J Dermatol. 2012 Oct;167(4):949-51. doi: 10.1111/j.1365-2133.2012.10983.x. Epub 2012 Jul 5. Br J Dermatol. 2012. PMID: 22486276 No abstract available.

3

The natural history of eczema from birth to adult life: a cohort study.

Burr ML, Dunstan FD, Hand S, Ingram JR, Jones KP. Burr ML, et al. Among authors: ingram jr. Br J Dermatol. 2013 Jun;168(6):1339-42. doi: 10.1111/bjd.12216. Br J Dermatol. 2013. PMID: 23301666

4

Phenotypic heterogeneity in hidradenitis suppurativa (acne inversa): classification is an essential step toward personalized therapy.

Ingram JR, Piguet V. Ingram JR, et al. J Invest Dermatol. 2013 Jun;133(6):1453-6. doi: 10.1038/jid.2012.476. J Invest Dermatol. 2013. PMID: 23673498 Free article.

5

Interpreting outcome measures and defining treatment success.

Ingram JR. Ingram JR. Br J Dermatol. 2013 Dec;169(6):1177-8. doi: 10.1111/bjd.12709. Br J Dermatol. 2013. PMID: 24299526 No abstract available.

6

The Hidradenitis Suppurativa Priority Setting Partnership.

Ingram JR, Abbott R, Ghazavi M, Alexandroff AB, McPhee M, Burton T, Clarke T. Ingram JR, et al. Br J Dermatol. 2014 Dec;171(6):1422-7. doi: 10.1111/bjd.13163. Epub 2014 Oct 30. Br J Dermatol. 2014. PMID: 24903313

7

Hidradenitis suppurativa outcome measures and treatment goals.

Ingram JR. Ingram JR. Br J Dermatol. 2014 Dec;171(6):1293-4. doi: 10.1111/bjd.13396. Br J Dermatol. 2014. PMID: 25523257 No abstract available.

8

Practical experience of biologics for treatment of very severe psoriasis: a retrospective case cohort study of patients with a baseline Psoriasis Area and Severity Index greater than 20.

Ponnambath N, Kalavala M, Anstey AV, Piguet V, Ingram JR. Ponnambath N, et al. Among authors: ingram jr. Clin Exp Dermatol. 2016 Jan;41(1):95-6. doi: 10.1111/ced.12651. Epub 2015 Mar 28. Clin Exp Dermatol. 2016. PMID: 25817265 No abstract available.

9

Management of hidradenitis suppurativa: a U.K. survey of current practice.

Ingram JR, McPhee M. Ingram JR, et al. Br J Dermatol. 2015 Oct;173(4):1070-2. doi: 10.1111/bjd.13866. Epub 2015 Aug 22. Br J Dermatol. 2015. PMID: 25913663 No abstract available.

10

Oral fumaric acid esters for psoriasis.

Atwan A, Ingram JR, Abbott R, Kelson MJ, Pickles T, Bauer A, Piguet V. Atwan A, et al. Among authors: ingram jr. Cochrane Database Syst Rev. 2015 Aug 10;2015(8):CD010497. doi: 10.1002/14651858.CD010497.pub2. Cochrane Database Syst Rev. 2015. PMID: 26258748 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

436 results

Search Page

Filters